Motif Bio

Motif Bio PLC is a United Kingdom-based clinical-stage biopharmaceutical company which specializes in developing antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. The Company has a lead antibiotic candidate, Iclaprim, and MTF-001, a preclinical program.-based on iclaprim and other lead compounds, the Company is engaged in the development of a lead series with the objective of identifying a DHFRi that is effective against a broad spectrum of gram positive bacteria, including those resistant to available antibiotics, that can be administered once daily in injectable (I/V) and oral (pill) formulations. The Company's other programs include programs in various-stages of development by building a portfolio of antibiotics by licensing drug candidates from organizations specialized in antibacterial research.
London, GB
Size (employees)
1 (est)
Motif Bio is headquartered in London, GB

Motif Bio Office Locations

Motif Bio has offices in London, New York
London, GB
New York, US

Motif Bio Metrics

Motif Bio Summary

Market capitalization

£26.6 M

Closing share price

Motif Bio's current market capitalization is £26.6 M.

Motif Bio Market Value History

Motif Bio News

Motif Bio Company Life

You may also be interested in